WARNER-LAMBERT SEEKS CATEGORY I STATUS FOR LISTERINE AS ORAL ANTISEPTIC
This article was originally published in The Rose Sheet
Executive Summary
WARNER-LAMBERT SEEKS CATEGORY I STATUS FOR LISTERINE AS ORAL ANTISEPTIC in an Aug. 5 submission to FDA. The company is asking for Category I status for both Listerine and Cool Mint Listerine based on in vitro and in vivo data supporting the antibacterial efficacy of the mouthwashes. Both products, Warner-Lambert noted, contain a "fixed combination" of four essential oils -- eucalyptol (.092%), menthol (.042%), methyl salicylate (.060%) and thymol (.064%) -- in hydroalcoholic vehicles.